Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma
Keyword(s):
Phase 2
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8167-8167
◽